Iraq vs Latvia: Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and
Iraq
22.7%
in 2021
Latvia
22.7%
in 2021
Iraq rank
50th
Latvia rank
50th
Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and over time
- Iraq
- Latvia
How they compare
Iraq currently reports 22.7% against 22.7% in Latvia, a difference of 0.0%.
The two have swapped places 4 times across 22 shared years of data; in 2000 it was Latvia ahead.
Iraq ranks 50th and Latvia ranks 50th of 185 countries.
Across the 3 decades both report, Iraq averaged higher in 1 and Latvia in 2.
Head to head by decade
| Decade | Iraq | Latvia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 26.1% | 28.2% | 2.1% | Latvia |
| 2010s | 23.1% | 23.2% | 0.1% | Latvia |
| 2020s | 23.6% | 21.9% | 1.8% | Iraq |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher mortality from cvd, cancer, diabetes or crd between exact ages 30 and, Iraq or Latvia?
- Iraq, at 22.7% against 22.7% in Latvia as of 2021.
- What is the difference in mortality from cvd, cancer, diabetes or crd between exact ages 30 and between Iraq and Latvia?
- 0.0%, with Iraq ahead.
- How many years of comparable data are there for Iraq and Latvia?
- 22 years are reported by both, from 2000 to 2021.
- How do Iraq and Latvia rank globally for mortality from cvd, cancer, diabetes or crd between exact ages 30 and?
- Iraq ranks 50th and Latvia ranks 50th of 185 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory Data Repository (http://apps.who.int/ghodata/)., World Health Organization (WHO), published as Mortality from CVD, cancer, diabetes or CRD between exact ages 30 and 70 (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Mortality from CVD, cancer, diabetes or CRD is the percent of 30-year-old-people who would die before their 70th birthday from any of cardiovascular disease, cancer, diabetes, or chronic respiratory disease, assuming that s/he would experience current mortality rates at every age and s/he would not die from any other cause of death (e.g., injuries or HIV/AIDS).